After its government lost a free trade agreement battle over its sovereign laws, Canada might now think turnabout is fair play . . .
SORRY! This content is exclusively for paying members. If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.
|
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.
Berkshire Hathaway financial report for the third quarter ended September 30, 2016. Berkshire Hathaway Note 1. General The accompanying unaudited Consolidated Financial Statements include the accounts of Berkshire Hathaway Inc. (“Berkshire” or... read more
RMB's Inclusion Could Spark Big Reshuffle by Dan Steinbock THE inclusion of the renminbi in the currency reserve basket is only a matter of time. It could trigger a US$1... read more
Is the idea of a buyout of Coca-Cola that far-fetched? Coca-Cola's buyout by 3G Capital? Earlier this year when David Winters, CEO of Wintergreen Asset Management, advanced the notion that a... read more
Mittleman Investment Management, LLC’s composite advanced 19.1% net of fees in the third quarter of 2018, versus gains of 7.7% in the S&P 500 Total Return Index and 3.6%... read more
In the early stages of his career, Warren Buffett was gifted with some fantastic opportunities. One such opportunity was National American Fire Insurance, a company that went through its... read more
Third Point Reinsurance investor presentation for the month of August 2016. Third Point Reinsurance - Our Company Specialty property & casualty reinsurer based in Bermuda A- (Excellent) financial strength rating... read more
In this session, Aswath Damodaran looks at the process of estimating equity risk premiums for countries and then extend that discussion to estimating it for a company. Aswath Damodaran: Equity... read more
The Kyle Bass pharma "short activism"continues this time against Biogen... UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ Coalition For Affordable Drugs V LLC Petitioner v. Biogen IDEC International GmbH Patent... read more
Tyler here with this week’s Macro Musings. As always, if you come across something cool during the week, shoot me an email at tyler@macro-ops.com and I’ll share it with the... read more
Foreign exchange traders are changing sides on the Japanese Yen (NYSEARCA:FXY). Back in February, the Bank of Japan came out and said that they had increased the size of... read more
Here’s a Tip: Read What Professional Investors Read
ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.
It’s THE resource for value investing and hedge funds. 📈
And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.
Sign up now. 👇
